EpiBone, Inc. Secures Funding Round Led by Kendall Capital Partners to Accelerate Global Expansion of Clinical Trials
Press Releases
EpiBone, Inc.  
November 8, 2024

EpiBone, Inc. Secures Funding Round Led by Kendall Capital Partners to Accelerate Global Expansion of Clinical Trials

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- EpiBone, Inc., a leading regenerative medicine company at the forefront of skeletal repair, announces the successful close of a convertible note funding round

avatar profile Olean Times Herald

Olean Times Herald


Local & Social